4.7 Article

Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008-11

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 70, 期 7, 页码 1981-1988

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkv055

关键词

MLST; MBLs; VIM; integrons; plasmids

资金

  1. European Commission [LSHP-CT-2007-037941]
  2. Polish National Science Centre [UMO-2012/07/B/NZ6/03528]
  3. Ministry of Health of the Czech Republic [NT11032-6/2010]
  4. Charles University Research Fund [P36]
  5. Education for Competitiveness Operational Programme - ESF [CZ.1.07/2.3.00/30.0022]
  6. Government of the Czech Republic

向作者/读者索取更多资源

Objectives: The objective of this study was to perform a multinational survey of patients' colonization by metallo-beta-lactamase (MBL)-producing Enterobacteriaceae, including their molecular characterization. Methods: Patients in 18 hospital units across Europe and Israel (n = 17945) were screened between mid-2008 and mid-2011. MBL-producing isolates were typed by PFGE and MLST. MBL genes were amplified and sequenced within their integrons. Plasmids with MBL genes were analysed by nuclease S1 plus hybridization profiling, mating and transformation assays, and by PCR-based replicon typing. Results: Ninety-one patients in nine centres (six countries), including 62 patients in two Greek ICUs, carried 94 non-duplicate MBL-producing organisms. Klebsiella pneumoniae isolates from Greece dominated (n = 57) and belonged mainly to ST147, ST36 and ST383. All but one of the isolates expressed VIM-1-type MBLs. Isolates of Greek origins produced five enzymes, including new VIM-39, encoded by class 1 integrons of four types. In-e541-like elements prevailed, comprising six variants located on IncR, IncFII(K), IncR+FIIK, IncR+A/C or non-typeable plasmids. The other group were new In4873 and In4863, being the first In416-like elements identified in Greece, which were present on IncA/C or non-typeable plasmids. Isolates from other countries produced only VIM-1 and the major integron was In916, identified in 16 organisms from France, Italy and Spain. In916 was carried by four plasmid types, including IncA/C, IncFII(K) and IncHI2. Other integrons included a new element, In3103, in Spain and In110 identified only in Latvia. Conclusions: This study provided fully comparable data on the occurrence and molecular characteristics of VIM-producing Enterobacteriaceae in a group of hospital units across Europe, documenting recent changes in their epidemiology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Quality of MALDI-TOF mass spectra in routine diagnostics: results from an international external quality assessment including 36 laboratories from 12 countries using 47 challenging bacterial strains

Aline Cuenod, Martina Aerni, Claudia Bagutti, Banu Bayraktar, Efe Serkan Boz, Cynthia Beisert Carneiro, Carlo Casanova, Alix T. Coste, Peter Damborg, Dirk W. van Dam, Mehmet Demirci, Pavel Drevinek, Olivier Dubuis, Jose Fernandez, Gilbert Greub, Jaroslav Hrabak, Gulen Hurkal Yigitler, Jakub Hurych, Thoger Gorm Jensen, Geraldine Jost, Greetje A. Kampinga, Sonja Kittl, Christine Lammens, Claudia Lang, Reto Lienhard, Julie Logan, Carola Maffioli, Ivana Marekovic, Matthias Marschal, Jacob Moran-Gilad, Oliver Nolte, Michael Oberle, Michael Pedersen, Valentin Pfluger, Sigrid Pranghofer, Julia Reichl, Rob J. Rentenaar, Arnaud Riat, Belen Rodriguez-Sanchez, Camille Schilt, Ann-Kathrin Schlotterbeck, Jacques Schrenzel, Shani Troib, Elise Willems, Mandy Wootton, Dominik Ziegler, Adrian Egli

Summary: The study assessed the mass spectral quality (MSQ) of MALDI-TOF MS and identified simple workflow adaptations to improve it. The intervention of providing feedback and instructions on acquiring MALDI-TOF mass spectra showed improvements in MSQs.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Editorial Material Infectious Diseases

Platform trials as the way forward in infectious disease' clinical research: the case of coronavirus disease 2019

Juan M. Pericas, Lennie P. G. Derde, Scott M. Berry

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Medicine, General & Internal

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Alisa M. Higgins, Lindsay R. Berry, Elizabeth Lorenzi, Srinivas Murthy, Zoe McQuilten, Paul R. Mouncey, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Abi Beane, Wilma Van Bentum-Puijk, Zahra Bhimani, Marc J. M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Aiden Burrell, Adrian Buzgau, Meredith Buxton, Walton N. Charles, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Elizabeth O. Fagbodun, Mark Fitzgerald, Timothy D. Girard, Ewan C. Goligher, Herman Goossens, Rashan Haniffa, Thomas Hills, Christopher M. Horvat, David T. Huang, Nao Ichihara, Francois Lamontagne, John C. Marshall, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Bryan J. McVerry, Matthew D. Neal, Alistair D. Nichol, Rachael L. Parke, Jane C. Parker, Karen Parry-Billings, Sam E. C. Peters, Luis F. Reyes, Kathryn M. Rowan, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Ary Serpa-Neto, Christopher W. Seymour, Manu Shankar-Hari, Lucy M. Stronach, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Lennie P. G. Derde, Anthony C. Gordon, Steve A. Webb, Patrick R. Lawler

Summary: The longer-term effects of therapies for critically ill COVID-19 patients are unknown. In this study, 4869 patients were randomized to receive different interventions, and it was found that treatment with IL-6 receptor antagonists and antiplatelet agents significantly improved survival rates after 180 days. These findings suggest that most therapies have consistent effects over a 6-month period.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Microbiology

Implication of different replicons in the spread of the VIM-1-encoding integron, In110, in Enterobacterales from Czech hospitals

Ibrahim Bitar, Costas C. Papagiannitsis, Lucie Kraftova, Vittoria Mattioni Marchetti, Efthymia Petinaki, Marc Finianos, Katerina Chudejova, Helena Zemlickova, Jaroslav Hrabak

Summary: This study aimed to characterize the genetic elements involved in the increased spread of bla(VIM) genes in VIM-producing Enterobacterales isolated from Czech hospitals between 2019 and 2020. The results showed variations in carbapenem susceptibility among the isolates, with bla(VIM-1) and bla(VIM-4) genes being prevalent. Multiple integrons and plasmids carrying the bla(VIM) genes were identified, indicating the ongoing evolution and spread of VIM-encoding integrons.

FRONTIERS IN MICROBIOLOGY (2023)

Article Respiratory System

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

Ignacio Martin-Loeches, Antoni Torres, Blin Nagavci, Stefano Aliberti, Massimo Antonelli, Matteo Bassetti, Lieuwe Bos, James Chalmers, Lennie Derde, Jan de Waele, Jose Garnacho-Montero, Marin Kollef, Carlos Luna, Rosario Menendez, Michael Niederman, Dimitry Ponomarev, Marcos Restrepo, David Rigau, Marcus Schultz, Emmanuele Weiss, Tobias Welte, Richard Wunderink

Summary: The ERS, ESICM, ESCMID and ALAT have developed the first international guidelines for severe community-acquired pneumonia (sCAP). These guidelines provide evidence-based recommendations for diagnosis, empirical treatment and antibiotic therapy for sCAP.

EUROPEAN RESPIRATORY JOURNAL (2023)

Correction Critical Care Medicine

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (Apr, 10.1007/s00134-023-07033-8, 2023)

Ignacio Martin-Loeches, Antoni Torres, Blin Nagavci, Stefano Aliberti, Massimo Antonelli, Matteo Bassetti, Lieuwe D. Bos, James D. Chalmers, Lennie Derde, Jan De Waele, Jose Garnacho-Montero, Marin Kollef, Carlos M. Luna, Rosario Menendez, Michael S. Niederman, Dmitry Ponomarev, Marcos I. Restrepo, David Rigau, Marcus J. Schultz, Emmanuel Weiss, Tobias Welte, Richard Wunderink

INTENSIVE CARE MEDICINE (2023)

Letter Critical Care Medicine

Continuation of therapeutic dose heparin for critically ill patients with COVID-19

Charlotte A. Bradbury, Patrick R. Lawler, Bryan J. McVerry, Ryan Zarychanski, REMAP C A P Investigators

INTENSIVE CARE MEDICINE (2023)

Article Medicine, General & Internal

Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19

Ewan C. C. Goligher, Patrick R. R. Lawler, Thomas P. P. Jensen, Victor Talisa, Lindsay R. R. Berry, Elizabeth Lorenzi, Bryan J. J. McVerry, Chung-Chou Ho Chang, Eric Leifer, Charlotte Bradbury, Jeffrey Berger, Beverly J. J. Hunt, Lana A. A. Castellucci, Lucy Z. Kornblith, Anthony C. C. Gordon, Colin McArthur, Steven Webb, Judith Hochman, Matthew D. D. Neal, Ryan Zarychanski, Scott Berry, Derek C. C. Angus

Summary: This study aimed to evaluate the heterogeneity of treatment effect (HTE) of therapeutic-dose heparin in patients hospitalized for COVID-19 and compare different approaches to assessing HTE. The findings showed that the effect of therapeutic-dose heparin varied among patients with different severity levels and BMI, with more benefit observed in less severe or lower BMI patients and more harm in sicker or higher BMI patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Medicine, General & Internal

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19 A Randomized Clinical Trial

Patrick R. Lawler, Lennie P. G. Derde, Frank L. van de Veerdonk, Bryan J. McVerry, David T. Huang, Lindsay R. Berry, Elizabeth Lorenzi, Roland van Kimmenade, Frank Gommans, Muthiah Vaduganathan, David E. Leaf, Rebecca M. Baron, Edy Y. Kim, Claudia Frankfurter, Slava Epelman, Yvonne Kwan, Richard Grieve, Stephen O'Neill, Zia Sadique, Michael Puskarich, John C. Marshall, Alisa M. Higgins, Paul R. Mouncey, Kathryn M. Rowan, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Carly Au, Abi Beane, Wilma van Bentum-Puijk, Marc J. M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Aidan Burrell, Adrian Buzgau, Meredith Buxton, Maurizio Cecconi, Allen C. Cheng, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Justin Ezekowitz, Mark Fitzgerald, David Gattas, Lucas C. Godoy, Herman Goossens, Rashan Haniffa, David A. Harrison, Thomas Hills, Christopher M. Horvat, Nao Ichihara, Francois Lamontagne, Kelsey M. Linstrum, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Zoe McQuilten, Srinivas Murthy, Alistair D. Nichol, David R. J. Owen, Rachael L. Parke, Jane C. Parker, Katrina M. Pollock, Luis Felipe Reyes, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Christopher W. Seymour, Manu Shankar-Hari, Vanessa Singh, Alexis F. Turgeon, Anne M. Turner, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Scott Berry, Anthony C. Gordon, Colin J. McArthur, Steve A. Webb

Summary: In patients with COVID-19, overactivation of the renin-angiotensin system (RAS) may have negative clinical outcomes. This study aimed to determine if initiating angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) could improve outcomes in hospitalized COVID-19 patients. The results showed that in critically ill patients, the use of ACE inhibitors or ARBs did not improve, and likely worsened, clinical outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Medicine, General & Internal

Cohort profile of PLUTO: a perioperative biobank focusing on prediction and early diagnosis of postoperative complications

Nikki de Mul, Diede Verlaan, Jelle P. Ruurda, Wilhelmina M. U. van Grevenstein, Jeroen Hagendoorn, Gert-Jan de Borst, Menno R. Vriens, Remco de Bree, Ronald P. Zweemer, Charles Vogely, Jelle L. G. Haitsma Mulier, Lisette M. Vernooij, Johannes B. Reitsma, Marcel R. de Zoete, Janetta Top, Jan A. J. Kluijtmans, Imo E. Hoefer, Peter Noordzij, Thijs Rettig, Marije Marsman, Anne Marie G. A. de Smet, Lennie Derde, Judith van Waes, Mienke Rijsdijk, Willem Jan M. Schellekens, Marc J. M. Bonten, Arjen J. C. Slooter, Olaf L. Cremer

Summary: The PLUTO cohort study aims to establish a comprehensive biorepository to facilitate research on perioperative complications and long-term outcomes. Participants are patients undergoing non-cardiac surgery. The study focuses on postoperative occurrences such as infections, cardiac events, pulmonary complications, kidney injury, and delirium/acute encephalopathy.

BMJ OPEN (2023)

Article Biochemical Research Methods

The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chips

Josef Dvorak, Jana Novakova, Lucie Kraftova, Vendula Studentova, Martin Matejovic, Jaroslav Radej, Thomas Karvunidis, Jan Horak, Marcela Kralovcova, Jaroslav Hrabak, Zuzana Kalaninova, Michael Volny, Petr Novak, Petr Pompach

Summary: A rapid PCT detection method using MALDI-TOF mass spectrometry was developed and validated against LC-MS bottom-up workflow. The new method detects intact PCT and uncovers its alterations in septic patients' serum.

CLINICAL PROTEOMICS (2023)

Article Microbiology

Polyclonal Spread of Fosfomycin Resistance among Carbapenemase-Producing Members of the Enterobacterales in the Czech Republic

V. Mattioni Marchetti, L. Kraftova, M. Finianos, T. Sourenian, J. Hrabak, I. Bitar

Summary: The study investigated fosfomycin susceptibility profiles among carbapenem-resistant Enterobacterales (CRE) in the Czech Republic, characterized the genetic environment of fosA genes, and evaluated the presence of amino acid mutations in proteins involved in FOS resistance mechanisms. The results showed the occurrence of several FOS resistance mechanisms in different clones spreading in the Czech Republic.

MICROBIOLOGY SPECTRUM (2023)

Article Biochemistry & Molecular Biology

Clinical Validation of GenBody COVID-19 Ag, Nasal and Nasopharyngeal Rapid Antigen Tests for Detection of SARS-CoV-2 in European Adult Population

Karolina Wegrzynska, Jaroslaw Walory, Radoslaw Charkiewicz, Marzena Anna Lewandowska, Izabela Wasko, Aleksandra Kozinska, Piotr Majewski, Anna Baraniak

Summary: Accurate and rapid identification of COVID-19 is critical. The GenBody COVID-19 Ag rapid antigen tests showed high sensitivity and specificity, making them suitable for diagnosis and timely isolation and treatment of COVID-19 patients, contributing to the better control of virus spread.

BIOMEDICINES (2023)

Article Immunology

Twenty-Month Monitoring of Humoral Immune Response to BNT162b2 Vaccine: Antibody Kinetics, Breakthrough Infections, and Adverse Effects

Jaroslaw Walory, Iza Ksiazek, Michal Karynski, Anna Baraniak

Summary: This study found that the BNT162b2 vaccine had strong immunogenicity, but antibody levels declined over time, potentially contributing to breakthrough infections. Booster doses significantly enhanced antibody levels and provided longer-lasting immunity compared to breakthrough infection.

VACCINES (2023)

Article Critical Care Medicine

Decision-making regarding antibiotic therapy duration: An observational study of multidisciplinary meetings in the intensive care unit

Robin M. E. Janssen, Anke J. M. Oerlemans, Johannes G. van der Hoeven, Evelien A. N. Oostdijk, Lennie P. G. Derde, Jaap ten Oever, Heiman F. L. Wertheim, Marlies E. J. L. Hulscher, Jeroen A. Schouten

Summary: This study provides insight into the decision-making process on antibiotic therapy duration in intensive care units (ICUs) through direct observations of multidisciplinary meetings in four Dutch ICUs. The findings reveal that the decision-making process for antibiotic therapy duration is complex, involving various healthcare professionals and utilizing different types of arguments.

JOURNAL OF CRITICAL CARE (2023)

暂无数据